CJC-1295 and Ipamorelin: Growth Hormone Peptide Stack Research
An evidence-based review of the most-studied growth hormone peptide pairing. Covers how CJC-1295 and Ipamorelin work through two different receptors, the DAC vs no-DAC distinction, why they're combined, and the research behind the stack.
By Tier One Research Team —
References
- Sustained effects of CJC-1295, a long-acting growth hormone-releasing hormone analog, on growth hormone and insulin-like growth factor I in healthy adults — J CLIN ENDOCRINOL METAB (2006)
- Ipamorelin, the first selective growth hormone secretagogue — EUR J ENDOCRINOL (1998)
- Growth hormone (GH)-releasing peptide stimulates GH release in normal men and acts synergistically with GH-releasing hormone — J CLIN ENDOCRINOL METAB (1990)
- CJC-1295 — WIKIPEDIA
- Ipamorelin — WIKIPEDIA